Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Immune-Related AEs Predict Outcomes in Advanced GU Cancers Immune-Related AEs Predict Outcomes in Advanced GU Cancers
Patients with advanced GU cancers who had immune-related AEs from immunotherapy had better overall survival — a phenomenon also reported for other cancer types.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
ASCO Insights: Impacts on Lung Cancer Care ASCO Insights: Impacts on Lung Cancer Care
Dr Mark Kris discusses conversations from ASCO 2023 that may affect the care of patients with lung cancers.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
US FDA Puts Hold on Gilead's Blood Cancer Therapy Trials US FDA Puts Hold on Gilead's Blood Cancer Therapy Trials
Gilead Sciences said on Wednesday the U.S. Food and Drug Administration had put a hold on trials testing the company ' s blood cancer drug following increased risk of patient...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait
A large retrospective study addressed the risk of opting for " watch and wait " in rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
SBRT Safe, Effective for Patients With Nonspine Bone Mets SBRT Safe, Effective for Patients With Nonspine Bone Mets
Stereotactic body radiation for nonspine bone metastases is associated with a low rate of local failures, fractures, and acute toxicity, according to a large meta-analytic review.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Machine Learning Helps Predict HCC Risk in MASLD Machine Learning Helps Predict HCC Risk in MASLD
A machine learning model can help estimate the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC
A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Does Eliminating Alcohol Intake Lower Cancer Risk? Does Eliminating Alcohol Intake Lower Cancer Risk?
When it comes to the link, a new report from WHO revealed limited or inadequate evidence to suggest consuming less alcohol or stopping altogether reduced the risk for most cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
DUO-E: PARP Inhibitor Combination Improves Survival DUO-E: PARP Inhibitor Combination Improves Survival
Dr Maurie Markman discusses results from the DUO-E trial.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Adding Apalutamide Boosts PSA Control in Prostate Cancer Adding Apalutamide Boosts PSA Control in Prostate Cancer
Adding apalutamide to androgen deprivation therapy (ADT) prolongs prostate-specific antigen progression-free survival in patients with biochemically recurrent prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Will Germany Open the Gateway to Cannabis Medicine? Will Germany Open the Gateway to Cannabis Medicine?
Rescheduling cannabis won ' t solve the research glut.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 5, 2024 Category: Cancer & Oncology Tags: Psychiatry Source Type: news
Doc Sues State Over'Antiquated' Telehealth Rules Doc Sues State Over'Antiquated' Telehealth Rules
Antiquated laws requiring oncologists and other doctors offering telehealth to have medical licenses in multiple states unnecessarily restrict patient access, a New Jersey lawsuit claimed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 2, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news
Team IDs Key Factors for Synthetic Control Arm in Mets CRC Team IDs Key Factors for Synthetic Control Arm in Mets CRC
Researchers identified a handful of prognostic factors to create a synthetic control arm, which can ultimately replace placebo control arms in future trials of salvage-line metastatic CRC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
WHO: Global Cancer Burden Rising Amid Striking Inequities WHO: Global Cancer Burden Rising Amid Striking Inequities
Globally, an estimated 20 million people developed cancer in 2022 -- a figure expected to increase 77% to 35 million by 2050, with poorer countries bearing the brunt, according to new data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Study Reveals Disparities in CRC Biomarker Testing Trends Study Reveals Disparities in CRC Biomarker Testing Trends
Testing trends are consistent with guideline recommendations and FDA approvals, but demographic disparities exist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
